Mótyán, J. A.,
Kassay, N.,
Matúz, K.,
Tőzsér, J.:
Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors.
Viruses-Basel. 14 (9), 1-17, (article identifier: 1888), 2022.
Kassay, N.,
Mótyán, J. A.,
Matúz, K.,
Golda, M.,
Tőzsér, J.:
Biochemical Characterization, Specificity and Inhibition Studies of HTLV-1, HTLV-2, and HTLV-3 Proteases.
Life (Basel). 11 (2), 1-21, (article identifier: 127), 2021.
Mahdi, M.,
Matúz, K.,
Tóth, F.,
Tőzsér, J.:
A Modular System to Evaluate the Efficacy of Protease Inhibitors against HIV-2.
PLoS One. 9 (11), 1-13, (article identifier: 113221), 2014.
D1
Agricultural and Biological Sciences (miscellaneous)
Q1
Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1
Medicine (miscellaneous)
2013
7.
Louis, J. M.,
Tőzsér, J.,
Roche, J.,
Matúz, K.,
Aniana, A.,
Sayer, J. M.:
Enhanced stability of monomer fold correlates with extreme drug resistance of HIV-1 protease.
Biochemistry. 52 (43), 7678-7688, 2013.
Matúz, K.,
Mótyán, J. A.,
Li, M.,
Wlodawer, A.,
Tőzsér, J.:
Inhibition of XMRV and HIV-1 proteases by pepstatin A and acetyl-pepstatin.
FEBS J. 279 (17), 3276-3286, 2012.
Li, M.,
Gustchina, A.,
Matúz, K.,
Tőzsér, J.,
Namwong, S.,
Goldfarb, N. E.,
Dunn, B. M.,
Wlodawer, A.:
Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease.
FEBS J. 278 (22), 4413-4424, 2011.
Kádas, J.,
Boross, P.,
Weber, I. T.,
Bagossi, P.,
Matúz, K.,
Tőzsér, J.:
C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity.
Biochem. J. 416 (3), 357-364, 2008.
Sperka, T.,
Miklóssy, G.,
Tie, Y.,
Bagossi, P.,
Zahuczky, G.,
Boross, P.,
Matúz, K.,
Harrison, R. W.,
Weber, I. T.,
Tőzsér, J.:
Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus protease.
J. Gen. Virol. 88 (7), 2052-2063, 2007.
